chr14-67753745-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_015346.4(ZFYVE26):c.7150G>A(p.Val2384Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000744 in 1,613,658 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015346.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZFYVE26 | NM_015346.4 | c.7150G>A | p.Val2384Ile | missense_variant | 39/42 | ENST00000347230.9 | NP_056161.2 | |
ZFYVE26 | XM_047431173.1 | c.7150G>A | p.Val2384Ile | missense_variant | 39/42 | XP_047287129.1 | ||
ZFYVE26 | XM_047431174.1 | c.4825G>A | p.Val1609Ile | missense_variant | 28/31 | XP_047287130.1 | ||
ZFYVE26 | XM_047431175.1 | c.4732G>A | p.Val1578Ile | missense_variant | 28/31 | XP_047287131.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZFYVE26 | ENST00000347230.9 | c.7150G>A | p.Val2384Ile | missense_variant | 39/42 | 1 | NM_015346.4 | ENSP00000251119.5 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152158Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000959 AC: 24AN: 250366Hom.: 0 AF XY: 0.0000813 AC XY: 11AN XY: 135312
GnomAD4 exome AF: 0.0000575 AC: 84AN: 1461382Hom.: 1 Cov.: 31 AF XY: 0.0000592 AC XY: 43AN XY: 726938
GnomAD4 genome AF: 0.000236 AC: 36AN: 152276Hom.: 1 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74470
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 17, 2022 | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 2384 of the ZFYVE26 protein (p.Val2384Ile). This variant is present in population databases (rs193074768, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with ZFYVE26-related conditions. ClinVar contains an entry for this variant (Variation ID: 220542). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2021 | The c.7150G>A (p.V2384I) alteration is located in exon 39 (coding exon 38) of the ZFYVE26 gene. This alteration results from a G to A substitution at nucleotide position 7150, causing the valine (V) at amino acid position 2384 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 08, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at